New Pill Promises Hair Regrowth
Tap title to read story
An experimental treatment that is a new spin on a classic medication could soon be the first new pill for pattern baldness in nearly 30 years.
Hair loss affects roughly 50 million men and 30 million women, and while there’s no special potion to reverse genetic or age‑related decline, some products may slow down loss and promote regrowth.
An oral, extended‑release version of minoxidil — the active ingredient in Rogaine — successfully regrew hair in men with pattern hair loss over six months in a phase 3 trial.
The study looked at 536 men with mild to moderate hair loss.
Patients were either given a once‑daily 8.5 mg dose of the experimental pill, known as VDPHL01, a twice‑daily dose or a placebo.
More context
Timeline
- On October 25 2026 New York Post reports VDPHL01 trial results.
Why it matters
Immediate US impact: Potential new treatment for millions of men Possible long-term US impact: Could shift hair loss market dynamics Most affected groups: Men experiencing pattern baldness Reader priority: Understand clinical efficacy and safety
Coverage notes
Center: Coverage from BBC Science Focus Magazine, India Today, ColombiaOne.com frames this as a developing news story: New Pill Promises Hair Regrowth. Reporting emphasizes verified facts, named sources, and near-term impact for readers. Left: Left-leaning desks covering the same development typically emphasize public impact, institutional accountability, and who is most affected. Right: Right-leaning desks covering the same development typically emphasize practical outcomes, market or security stakes, and institutional response.
Primary report
New York Post — New Pill Promises Hair Regrowth
Sources
JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.
